Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing

We present a new design of mixed-backbone antisense oligonucleotides (ASOs) containing both DNA and peptide nucleic acid (PNA). Previous generations of PNA–DNA chimeras showed low binding affinity, reducing their potential as therapeutics. The addition of a 5′-wing of locked nucleic acid as well as...

Full description

Saved in:
Bibliographic Details
Published inBiochemistry (Easton) Vol. 58; no. 6; pp. 582 - 589
Main Authors Debacker, Alexandre J, Sharma, Vivek K, Meda Krishnamurthy, Pranathi, O’Reilly, Daniel, Greenhill, Rachel, Watts, Jonathan K
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 12.02.2019
Online AccessGet full text

Cover

More Information
Summary:We present a new design of mixed-backbone antisense oligonucleotides (ASOs) containing both DNA and peptide nucleic acid (PNA). Previous generations of PNA–DNA chimeras showed low binding affinity, reducing their potential as therapeutics. The addition of a 5′-wing of locked nucleic acid as well as the combination of a modified nucleotide and a PNA monomer at the junction between PNA and DNA yielded high-affinity chimeras. The resulting ASOs demonstrated high serum stability and elicited robust RNase H-mediated cleavage of complementary RNA. These properties allowed the chimeric ASOs to demonstrate high gene silencing efficacy and potency in cells, comparable with those of LNA gapmer ASOs, via both lipid transfection and gymnosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-2960
1520-4995
DOI:10.1021/acs.biochem.8b00827